wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33862829-A39D5323-A131-410E-B9B3-1F2D8B3E2951
Q33862829-A39D5323-A131-410E-B9B3-1F2D8B3E2951
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33862829-A39D5323-A131-410E-B9B3-1F2D8B3E2951
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
P2860
Q33862829-A39D5323-A131-410E-B9B3-1F2D8B3E2951
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33862829-A39D5323-A131-410E-B9B3-1F2D8B3E2951
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
024f5e10839f3c012dda3c9165f3bbd778d2da32
P2860
Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro